Slingshot members are tracking this corporate initiative:
AstraZeneca (AZN) and Allergan (AGN) Complete Licensing Agreement for MEDI2070 Antibody Candidate in Mid-Stage Development for Crohn's Disease and Ulcerative Colitis
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Nov 17, 2016 Projected Implementation: Q1, 2017 Relevance Tracked Until: Q1, 2019
Don’t see a project related to the strategic initiative you care about?
Related Keywords Licensing Agreement, Medi2070, Monoclonal Antibody, Product Candidate, Crohn's Disease, Ulcerative Colitis